Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.56%. A quarter ago, it was expected that this company would post earnings of $0.12 per share when it actually produced earnings of $0.2, delivering a surprise of +66.67%.Over the last four quarters, the ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +130.43%. A quarter ago, it was expected that this company would post a loss of $0.19 per share when it actually produced earnings of $0.04, delivering a surprise of +121.05%.Over the last four qua ...

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of $0.09 per share when it actually produced a loss of $0.06, delivering a surprise of +33.33%.Over the last four quarters, the company ...

iRhythm Technologies (IRTC) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.61 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +39.62%. A quarter ago, it was expected that this company would post a loss of $0.89 per share when it actually produced a loss of $0.95, delivering a surprise of -6.74%. Over the last four quarters, the company ha ...

Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +45.16%. A quarter ago, it was expected that this Omnicell Inc. would post earnings of $0.16 per share when it actually produced earnings of $0.26, delivering a surprise of +62.5%.Over the last four quarters, the company ...

Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.39 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +5.00%. A quarter ago, it was expected that this company would post a loss of $0.37 per share when it actually produced a loss of $0.36, delivering a surprise of +2.7%. Over the last four quarters, the company has su ...

Key Takeaways Hims & Hers Health, Inc. (HIMS) is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell. In the last reported quarter, the company's earnings per share (EPS) of 20 cents topped the Zacks Consensus Estimate by 66.7%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on two occasions, missed once and broke even in the other, delivering an earnings surprise of 19.6%, on average. Let's check out the factors that have shaped HIMS' p ...

Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Doximity (DOCS) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revis ...

Doximity (DOCS) closed the most recent trading day at $59.70, moving -2.13% from the previous trading session. This change lagged the S&P 500's daily loss of 0.3%. Elsewhere, the Dow saw a downswing of 0.46%, while the tech-heavy Nasdaq depreciated by 0.38%. The medical social networking site's stock has dropped by 0.55% in the past month, falling short of the Medical sector's gain of 0.76% and the S&P 500's gain of 3.64%.The investment community will be paying close attention to the earnings performance of ...

Company Performance - Hims & Hers Health, Inc. (HIMS) closed at $58.68, marking a +1.79% move from the prior day, outperforming the S&P 500's daily gain of 0.02% [1] - The stock has risen by 16.68% in the past month, leading the Medical sector's gain of 1.92% and the S&P 500's gain of 4.93% [1] Upcoming Earnings - The company is scheduled to release its earnings on August 4, 2025, with projected earnings of $0.18 per share, representing year-over-year growth of 200% [2] - The consensus estimate for revenue is $551.84 million, reflecting a 74.83% rise from the equivalent quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.75 per share and revenue of $2.35 billion, signifying shifts of +177.78% and +58.88% respectively from the last year [3] Analyst Estimates and Confidence - Recent revisions in analyst estimates reflect the latest near-term business trends, with positive revisions indicating analysts' confidence in the business performance and profit potential [3][4] Zacks Rank and Performance - Hims & Hers Health, Inc. currently possesses a Zacks Rank of 1 (Strong Buy), with the Zacks Rank system showing an impressive track record of outperformance [5] - Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.27% higher [5] Valuation Metrics - The company has a Forward P/E ratio of 77.22, which is a premium compared to the average Forward P/E of 27.59 for its industry [6] - HIMS has a PEG ratio of 2.13, compared to the average PEG ratio for the Medical Info Systems industry, which stood at 3.15 [7] Industry Overview - The Medical Info Systems industry is part of the Medical sector and currently holds a Zacks Industry Rank of 74, placing it in the top 30% of all 250+ industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]